Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

SPRY.US Logo

SPRY.US - Current Price

$11.38

Company Information

Company Name
ARS Pharmaceuticals, Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US82835W1080
CIK: 0001671858
CUSIP: 82835W108
Currency: USD
Full Time Employees: 162
Phone: 858 771 9307
Fiscal Year End: December
IPO Date: Dec 04, 2020
Description:

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.

Address:

11682 El Camino Real, San Diego, CA, United States, 92130

Directors & Officers

Name Title Year Born
Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL Co-Founder, President, CEO & Director 1966
Dr. Sarina Tanimoto M.B.A., M.D. Co-Founder & Chief Medical Officer 1969
Mr. Brian T. Dorsey M.S. Chief Operating Officer 1969
Dr. Robert Bell Ph.D. Co-Founder & Chief Science Officer NA
Ms. Kathleen D. Scott CPA Chief Financial Officer NA
Mr. Alexander A. Fitzpatrick Esq. Chief Legal Officer & Secretary 1967
Mr. Daniel Relovsky Senior Vice President of Marketing NA
Ms. Lynda Harris Vice President of Human Resources NA
Mr. Justin Chakma Chief Business Officer 1990
Mr. Harris Kaplan M.B.A. Executive Vice President of Commercial Strategy 1952

Shares Statistics

Shares Outstanding: 98.85M
Shares Float: 105.41M
% Insiders: 1,682.60%
% Institutions: 8,658.30%
Short % Float: 33.80%

Valuation Metrics

Enterprise Value: $934.45M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $1.12B
EBITDA: $-89.81M
Book Value: $1.49
Earnings/Share: $-0.81
Profit Margin: -56.06%
Operating Margin: -163.66%
ROA (TTM): -19.22%
ROE (TTM): -45.92%
Revenue (TTM): $142.77M
Revenue/Share (TTM): $1.45
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 1,471.60%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

Date EPS Actual EPS Estimate Difference Surprise %
Mar 31, 2026 0.00 -0.48 N/A 10,000.00%
Dec 31, 2025 0.00 -0.42 N/A 10,000.00%
Sep 30, 2025 -0.52 -0.46 N/A -1,304.35%
Jun 30, 2025 -0.46 -0.46 N/A 0.00%
Mar 31, 2025 -0.35 -0.11 N/A -21,818.18%
Dec 31, 2024 0.51 -0.12 N/A 53,404.26%
Sep 30, 2024 -0.20 -0.15 N/A -3,333.33%
Jun 30, 2024 -0.13 -0.12 N/A -833.33%
Mar 31, 2024 -0.11 -0.11 N/A 0.00%
Dec 31, 2023 -0.07 -0.14 N/A 5,000.00%
Sep 30, 2023 -0.16 -0.18 N/A 1,111.11%
Jun 30, 2023 -0.18 -0.17 N/A -588.24%
Mar 31, 2023 -0.16 -0.17 N/A 588.24%
Dec 31, 2022 0.77 -0.13 N/A 69,230.77%
Sep 30, 2022 -0.50 -0.35 N/A -4,285.71%
Jun 30, 2022 -0.55 -0.48 N/A -1,458.33%
Mar 31, 2022 -0.70 -0.54 N/A -2,962.96%
Dec 31, 2021 -0.67 -0.70 N/A 428.57%
Sep 30, 2021 -0.65 -0.67 N/A 298.51%
Jun 30, 2021 -0.70 -0.53 N/A -3,207.55%
Mar 31, 2021 -0.54 -0.35 N/A -5,428.57%
Dec 31, 2020 -1.37 -0.49 N/A -17,959.18%
Sep 30, 2020 -0.70 -1.10 N/A 3,636.36%

Balance Sheet (Yearly)

Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $50.82M $N/A $351.15M $94.36M $256.80M
2023-12-31 $70.97M $N/A $233.19M $2.43M $230.76M
2022-12-31 $210.52M $N/A $281.44M $8.55M $272.89M
2021-12-31 $60.06M $N/A $61.45M $92.72M $-31.27M
2020-12-31 $24.52M $N/A $26.41M $40.46M $-14.05M
2019-12-31 $9.98M $N/A $15.65M $21.25M $-5.60M
2018-12-31 $20.16M $N/A $27.55M $9.35M $18.20M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Aug 21, 2025 N/A N/A N/A N/A N/A N/A
Aug 21, 2025 N/A N/A N/A N/A N/A N/A
Aug 20, 2025 N/A N/A N/A N/A N/A N/A
Aug 19, 2025 N/A N/A N/A N/A N/A N/A
Jul 01, 2025 N/A N/A N/A N/A N/A N/A
Jun 27, 2025 N/A N/A N/A N/A N/A N/A
Jun 18, 2025 N/A N/A N/A N/A N/A N/A
May 20, 2025 N/A N/A N/A N/A N/A N/A
May 20, 2025 N/A N/A N/A N/A N/A N/A
May 20, 2025 N/A N/A N/A N/A N/A N/A
Apr 07, 2025 N/A N/A N/A N/A N/A N/A
Mar 20, 2025 N/A N/A N/A N/A N/A N/A
Mar 06, 2025 N/A N/A N/A N/A N/A N/A
Feb 03, 2025 N/A N/A N/A N/A N/A N/A
Jan 06, 2025 N/A N/A N/A N/A N/A N/A
Dec 17, 2024 N/A N/A N/A N/A N/A N/A
Dec 13, 2024 N/A N/A N/A N/A N/A N/A
Dec 12, 2024 N/A N/A N/A N/A N/A N/A
Dec 10, 2024 N/A N/A N/A N/A N/A N/A
Dec 06, 2024 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist